4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-057159
EVP, R&D & Chief Scientific Of sold 6,000 shares at $14.35 ($86,100)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2017-10-16 | Sale | −6,000 | $14.35 | $86,100 | 343,305 | D: show line 1 in the form |
| Open-market sales · 6,000 sh · avg $14.35 · $86,100 | |||||||
Loading xslF345X03/doc4.xml…